Megan Elizabeth Hardin MD
Critical Care Medicine, Pleural Disease
Research Fellow in Medicine, Brigham and Women's Hospital
Join to View Full Profile
75 Francis StBoston, MA 02115
Phone+1 917-755-5085
Dr. Hardin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General Hospital/BIDMC/Harvard Medical SchoolFellowship, Pulmonary Disease and Critical Care Medicine, 2008 - 2012- Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2005 - 2008
Albert Einstein College of MedicineClass of 2005
Certifications & Licensure
MA State Medical License 2007 - 2024
Clinical Trials
- S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma Start of enrollment: 2009 Jul 01
- S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- Long-term dupilumab efficacy in type 2 asthma regardless of baseline characteristics.Michael E Wechsler, Linda Rogers, G Walter Canonica, Arnaud Bourdin, Arman Altincatal
ERJ Open Research. 2024-11-01 - 6 citationsBiomarkers Associated with Lung Function Decline and Dupilumab Response in Patients with Asthma.Ian D Pavord, Lucia De Prado Gómez, Guy Brusselle, Daniel J Jackson, Christopher E Brightling
American Journal of Respiratory and Critical Care Medicine. 2024-04-15 - 4 citationsDupilumab sustains lung function improvements in patients with moderate-to-severe asthma.Alberto Papi, Mario Castro, Jonathan Corren, Ian D Pavord, Yuji Tohda
Respiratory Medicine. 2024-04-01
Press Mentions
Sex Differences in COPD Slow to Be Recognized, TreatedApril 12th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
